Early and Delayed Hypersensitivity Reactions to Paclitaxel: Desensitization as A challenge by Lira Quezada, Cindy Elizabeth de et al.
S72 Abstracts: Medically Challenging Cases / Ann Allergy Asthma Immunol 121 (2018) S63−S134M027
EARLY AND DELAYED HYPERSENSITIVITY
REACTIONS TO PACLITAXEL:
DESENSITIZATION AS A CHALLENGE
C. De Lira-Quezada*1, A. Macias-Weinmann1, S. Gonzalez-Diaz1,
A. Arias-Cruz1, R. Villarreal Gonzalez1, I. Perez Gomez1,
R. Ramirez-Rodriguez2, 1. Monterrey, Nuevo Leon, Mexico;
2. Monterrey, Mexico
Introduction: Taxanes are among the most frequently implicated
antineoplastics in anaphylaxis and occur in around 1% of patients.
Immediate hypersensitivity reactions (HSR) to taxanes are generally
attributed to the surfactants used in their formulation however IgE
mediated reactions have been reported.
Case Description: A 36 year old female patient with breast cancer
stage IIB diagnosed on November 2017 was referred to our center by
the Oncology Service. Patient started chemotherapy with paclitaxel
120 mg, however 3 minutes after the second dose she presented pru-
ritus, chest pain and throat tightness; dexamethasone and clorphe-
niramine was administered by oncologist with complete resolution
of symptoms. We performed skin tests with paclitaxel (1 mg/1ml):
prick tests were negative, intradermal test (0.01 mg/ml) 0.05 ml was
positive (wheal was 5 mm greater than negative control). Desensiti-
zation was performed with an 8 hour method and total dose of
120 mg; premedication was methylprednisolone 40 mg, clorphenir-
amine 10 mg and ondansetron 8 mg. No immediate reactions
ocurred. Two days later patient presented cutaneous vasculitis lesions
in lower limbs and abdomen so 50 mg of prednisone for 7 days was
started. CBC, urinalysis, LDH and hepatic enzymes were normal. Skin
lesions resolved 2 days later. Treatment with docetaxel was consid-
ered as treatment despite high costs and limited availability for most
patients.
Discussion: Administration of docetaxel with premedication is con-
sidered as a treatment option however patients with delayed taxane-
induced HSRs, with onset of 48 hours or less after the infusion might
be at risk of an immediate reaction on re-exposure as reported with
our patient.M028
HORSEFLY-WASP SYNDROME
C. Punch*, T. Banks, C. Mikita, Bethesda, MD
Introduction:We present a 67 year old male who developed anaphy-
laxis after being bitten by a horseﬂy; likely a more common diagnosis
than previously documented.
Case Description: 67 year old male farmer presented to ED with
symptoms of anaphylaxis. He had eaten crab and ten minutes later
was bitten by a horseﬂy on his left hand. He became lightheaded,
developed left arm swelling, and itchy hands. Symptoms progressed
to peri-oral numbness, neck erythema, emesis and loss of conscious-
ness. His evaluation revealed positive speciﬁc IgE by serology to HB,
WA, YH, YJ, WFH, horseﬂy and crab. Six weeks later, patient success-
fully passed crab challenge. Probable horseﬂy-wasp syndrome sus-
pected and patient decided to undergo VIT to mixed vespids, wasp,
and honeybee.
Discussion: At least 30 cases of severe allergic reactions to horseﬂy
allergy (family Tabanidae) have been recorded; however, this is
thought to be underreported secondary to poor diagnostics and lack
of awareness. Clinically, a co-existence of anaphylaxis to horseﬂy and
hymenoptera has been reported. Tab y 2 (a hyaluronidase) and
Tab y 5 (antigen 5) have been identiﬁed as potential allergen proteins
from the saliva of the horseﬂy as well as wasp venom which supports
evidence of horseﬂy-wasp syndrome. Given the patient’s occupa-
tional risk, lack of speciﬁc immunotherapy for horseﬂy allergy, and
suspected cross reactivity between the wasp and horseﬂy, VIT for
wasp should be considered as a scientiﬁcally plausible but limited
treatment option for horseﬂy allergy.Downloaded for Anonymous User (n/a) at Autonomous University of Nu
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SUCCESSFUL DESENSITIZATION TO
PACLITAXEL: A CASE REPORT
R. Guzman Cotaya*, S. Gonzalez-Diaz, A. Arias-Cruz,
A. Macias-Weinmann, C. De Lira-Quezada, D. Roman Canamar,
R. Villarreal Gonzalez,Monterrey, Nuevo Leon, Mexico
Introduction: Antineoplastics are the third leading cause of death
due to drug-induced anaphylaxis. Taxanes are an integral part of the
chemotherapeutic regimen used in gynecological malignancies. Drug
desensitization is a therapeutic technique that induces a temporary
state of tolerance to a drug responsible for a hypersensitivity reaction.
Case Description: A 48 year old female diagnosed with stage IV
mixed epithelial ovarian cancer and arterial hypertension. Chemo-
therapy with carboplatin + paclitaxel is indicated, during the ﬁrst
cycle. She presents within the ﬁrst 5 minutes of application of pacli-
taxel: lipotimia and wheals, without hypotension, hypoxemia, or
wheezing. Skin tests are performed, resulting positive to paclitaxel at
dilution 1:1000, a protocol of desensitization was performed based
on 6 bags of sodium chloride, and paclitaxel in different concentra-
tions. The desensitization doses were administered within six hours
of preparation, and there was no reaction to the administration of the
medication.
Discussion: Hypersensitivity reactions are common with the admin-
istration of taxanes. A desensitization protocol was performed, con-
sidering it successful since the patient was able to continue her
treatment without adverse reactions.M030
DESENSITIZATION PROTOCOL FOR
HYPERSENSITIVITY TO CARBOPLATIN IN-
PATIENTWITHMETASTATIC CANCER, A
SAFE AND EFFECTIVE METHOD
R. Ramirez Rodriquez*, S. Gonzalez-Diaz, A. Macias-Weinmann,
A. Arias-Cruz, R. Villarreal Gonzalez,Monterrey, Neuvo Leon, Mexico
Introduction: Use of chemotherapy compounds in clinical practice is
increasing leading to a rise in the incidence of hypersensitivity reac-
tions. Reactions to carboplatin usually occur between the fourth and
eighth course of chemotherapy. The reaction manifests with rash,
dyspnea, tightness in the chest, hypotension/hypertension, edema,
back pain.
Case Description: 53-year-old male without history of atopy, with
metastatic adenocarcinoma in treatment with carboplatin and pacli-
taxel. During course number 6, at the end of the carboplatin infusion,
the patient showed a cutaneous eruption in the face and neck,
extended to the abdomen and chest, ﬁve minutes after presenting
foreign body sensation and dyspnea, the management was with
hydrocortisone and intravenous chlorpheniramine, the duration of
eruption was less than 1 hour. During the seventh course of chemo-
therapy, at the end of carboplatin the eruption returned with the
same characteristics, which remitted with hydrocortisone and chlor-
pheniramine. The patient was referred to our unit; skin test with car-
boplatin was performed. Prick test was negative and the intradermal
test (undiluted drug 10 mg / 1 ml) was positive. The patient under-
went carboplatin desensitization according to a 12-step protocol
(Table 1), with good drug tolerance and adequate clinical response.
Discussion: Hypersensitivity reactions to chemotherapy agents are
deﬁned as unexpected reactions with signs and symptoms inconsistentevo Leon from ClinicalKey.com by Elsevier on September 25, 2019.
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